Stepping Into the Era of Combination Cancer Therapies, Part 2: Combining Targeted Therapies
In my first post in this series highlighting some of the studies presented at the AACR Annual Meeting 2015...
Category: Research
In my first post in this series highlighting some of the studies presented at the AACR Annual Meeting 2015...
Tamas A. Gonda, MD, 2014 recipient of the Landon Foundation-AACR INNOVATOR Award for Cancer Prevention Research, is examining how...
Game-changing modern cancer therapies—immunotherapies and targeted therapies, among others—have been providing promising treatment outcomes in the recent years. The...
Immunotherapeutics called PD-1 inhibitors have garnered a lot of attention in the past year thanks to exciting clinical trial...
As Kidney Cancer Awareness Month draws to a close, Scott M. Welford, PhD, the 2014 recipient of the Kure...
Guest Post by Toni Kay Mangskau Mayo Clinic Cancer Center
There has been a series of immunotherapy approvals since the end of last year, and following this trend, on...
Guest Post by Dario C. Altieri, MD The Wistar Institute
The field of cancer immunotherapy broke new ground last week when the U.S. Food and Drug Administration (FDA) announced...
Just days before the start of multiple myeloma awareness month, which began Sunday, March 1, the U.S. Food and...